Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Jan. 21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback